Navigation Links
Transdel Pharmaceuticals to Present at Rodman & Renshaw 12th Annual Healthcare Conference
Date:9/7/2010

LA JOLLA, Calif., Sept. 7 /PRNewswire/ -- Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP) today announced that Transdel management will present a company overview at the Rodman & Renshaw 12th Annual Healthcare Conference in New York City on Monday, September 13, 2010 at 4:05 p.m. Eastern Time.

Interested parties can access a live webcast via the Internet by visiting the Investor Relations section of the Company's Web site at http://www.transdelpharma.com.

About Transdel Pharmaceuticals, Inc.

Transdel Pharmaceuticals, Inc. (OTCBB: TDLP) is a specialty pharmaceutical company developing non-invasive, topically delivered products. The Company's innovative-patented Transdel™ cream formulation technology is designed to facilitate the effective penetration of a variety of products through the tough skin barrier.  Ketotransdel®, the Company's lead pain product, has successfully completed a Phase 3 clinical trial and utilizes the Transdel technology to deliver the active drug, ketoprofen, a non-steroidal anti-inflammatory drug through the skin directly into the underlying tissues where the drug exerts its well-known anti-inflammatory and analgesic effects. The Company intends to leverage its Transdel™ platform technology to expand and create a portfolio of topical products for a variety of indications.  The Company is actively pursuing partnerships with companies to expand its product portfolio for pharmaceutical and cosmetic/cosmeceutical products.  For more information, please visit http://www.transdelpharma.com.

Safe Harbor Statement

The Company cautions you that the statements included in this press release that are not a description of historical facts are forward-looking state
'/>"/>

SOURCE Transdel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Transdel Pharmaceuticals to Present at Rodman & Renshaw 10th Annual Global Healthcare Conference
2. Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group
3. Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday, October 6, 2009 to Announce Top-Line Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel(R)
4. Transdel Pharmaceuticals to Present at Two Investor Conferences
5. Transdel Pharmaceuticals Reports First Quarter 2010 Results
6. Transdel Pharmaceuticals Enters into License Agreement with Jan Marini Skin Research for Cosmeceutical Product
7. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
8. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
9. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
10. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
11. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... 16, 2013 The Stirling Ultracold ... Cooling, Inc., Athens, OH, USA, won the Outstanding New ... International Society for Biological and Environmental Repositories (ISBER) at ... to one product annually, recognizes the company’s development and ... freezer. The award was presented to Global Cooling’s ...
(Date:5/16/2013)... Vernon Hills, Ill. (PRWEB) May 16, 2013 ... including benchtop and portable models, from Cole-Parmer is ... professionals. The enhanced line includes: , The new ... that are true workhorses in the lab. They ... superior serum and plasma specimen separation. Their standard ...
(Date:5/16/2013)... May 16, 2013  The registration deadline has been ... Officers (ABFO) 2013 National Conference, the premier conference for ... 28-31 at the Hilton San Diego Bayfront. ... year,s conference and want to make sure as many ... Brandi Roberts , Chief Financial Officer ...
(Date:5/16/2013)... 16, 2013 Reportlinker.com announces ... is available in its catalogue: ... Analysis: Therapeutic Proteins – Biosimilars, Biobetters ...   Product ... The new Competitive Intelligence Report Therapeutic ...
Breaking Biology Technology:Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia 2Cole-Parmer Offers Enhanced Selection of Centrifuges 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8
... Access, Inc. announces the appointment of Joe Alfrey ... Access organization with that of its joint venture ... gives clients in Southwestern US and Mexico access ... and mission-critical managed services. (Logo:   ...
... WOODLANDS, Texas, Oct. 7 US Oncology, ... uniting the largest cancer treatment and research network ... results for the third quarter of fiscal 2010 ... http://photos.prnewswire.com/prnh/20100517/DA06089LOGO ) (Logo:   http://www.newscom.com/cgi-bin/prnh/20100517/DA06089LOGO ) ...
... VIEW, Calif., Oct. 7 VIVUS, Inc. (Nasdaq: ... drug candidate, are highlighted in six poster presentations at the ... October 8-12, 2010 in San Diego, California. Following ... Society 28th Annual Scientific Meeting at The San Diego Convention ...
Cached Biology Technology:Castle Access Names New Managing Director 2Castle Access Names New Managing Director 3US Oncology to Report 2010 Third Quarter Operating Results 2Data on VIVUS' QNEXA to be Presented in Six Posters at The Obesity Society's Annual Meeting 2Data on VIVUS' QNEXA to be Presented in Six Posters at The Obesity Society's Annual Meeting 3Data on VIVUS' QNEXA to be Presented in Six Posters at The Obesity Society's Annual Meeting 4
(Date:5/17/2013)... all ages will celebrate the science and technology ... daily lives during the inaugural Atlanta Science Festival, ... from local museums, corporations, K-12 schools and universities, ... events for children and adults at venues across ... , The annual Atlanta Science Festival is ...
(Date:5/17/2013)... of American Societies for Experimental Biology (FASEB) released a ... (NIH) funding trends highlighting the devastating impact of sequestration ... FASEB analysis follows a May 15th Senate Appropriations Committee ... testified that the $1.6 billion cut the agency sustained ... substantial impact on the scientific community." , According ...
(Date:5/16/2013)... HOUSTON African-American adults living closer to a fast ... than those who lived further away from fast food, ... Anderson Cancer Center, and this association was particularly strong ... new study published online in the American Journal ... residential proximity to a fast food restaurant, and among ...
Breaking Biology News(10 mins):First Atlanta Science Festival set for 2014 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3
... microbes, tiny organisms that do big jobs in our environment, ... and possible extinction but may also play a key role ... published this week in the Proceedings of National Academy ... Jones described how they used a mathematical model and molecular ...
... - March 17, 2010) - Syngenta Crop Protection ... with Innovotech (TSX VENTURE:IOT), a Canadian biotechnology product ... trials in North America on the new plant ... this year Innovotech and Syngenta entered into a ...
... PITTSBURGH, MARCH 22, 2010 -- Significant numbers of today,s ... percent) say they were discouraged from pursuing a STEM ... in their lives, according to a new Bayer Corporation ... them as the leading place in the American education ...
Cached Biology News:Dormant microbes promote diversity, serve environment 2US women and minority scientists discouraged from pursuing STEM careers, national survey shows 2US women and minority scientists discouraged from pursuing STEM careers, national survey shows 3
S. O'Hare & C.K. Atterwill • In vitro toxicity techniques for regular lab use. Ex vivo techniques are also covered with the aim of reducing and refining the use of animals in the future....
Form: Concentrated Applications: ELISA...
RABBIT ANTI HALOPERIDOL...
Form: Ready to use Applications: Western Blot, ELISA...
Biology Products: